KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Prepaid Assets (2016 - 2026)

Pacira BioSciences has reported Prepaid Assets over the past 17 years, most recently at $36.8 million for Q1 2026.

  • For Q1 2026, Prepaid Assets rose 32.11% year-over-year to $36.8 million; the TTM value through Mar 2026 reached $36.8 million, up 32.11%, while the annual FY2025 figure was $32.6 million, 48.74% up from the prior year.
  • Prepaid Assets for Q1 2026 was $36.8 million at Pacira BioSciences, up from $32.6 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $43.5 million in Q3 2025 and troughed at $14.4 million in Q3 2022.
  • A 5-year average of $23.7 million and a median of $19.8 million in 2024 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: dropped 16.4% in 2023 and later skyrocketed 88.25% in 2025.
  • Year by year, Prepaid Assets stood at $15.2 million in 2022, then soared by 41.26% to $21.5 million in 2023, then rose by 1.98% to $21.9 million in 2024, then surged by 48.74% to $32.6 million in 2025, then grew by 12.75% to $36.8 million in 2026.
  • Business Quant data shows Prepaid Assets for PCRX at $36.8 million in Q1 2026, $32.6 million in Q4 2025, and $43.5 million in Q3 2025.